Sectoral Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Sectoral Asset Management’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,023,159	Closed	-$10.9M	–	77
2019 Q4	$10.9M	Buy	1,023,159 +345,400	+51%	+$3.43M	1.62%	25
2019 Q3	$7.05M	Buy	677,759 +11,601	+2%	+$152K	1.22%	36
2019 Q2	$10.2M	Buy	666,158 +70,100	+12%	+$1.01M	1.22%	32
2019 Q1	$7.66M	Buy	596,058 +557,220	+1,435%	+$6.3M	0.92%	40
2018 Q4	$369K	Buy	38,838 +20,300	+110%	+$263K	0.05%	71
2018 Q3	$308K	Buy	+18,538	New	+$297K	0.03%	107

Other funds holding STML

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Sectoral Asset Management's STML Position: Q1 2020 in Review

Sectoral Asset Management sold out of Stemline Therapeutics, Inc. (STML) in Q1 2020, closing a stake of 1,023,159 shares — an estimated $10.9M sold.

Sectoral Asset Management first reported a position in STML in Q3 2018 and held it in 6 quarters. The position peaked at $10.9M in Q4 2019. 94 funds tracked by Wall St. Rank hold STML as of Q1 2020.

Sectoral Asset Management reported no remaining Stemline Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Sectoral Asset Management sold 1,023,159 Stemline Therapeutics, Inc. shares in Q1 2020, an estimated $10.9M.
Sectoral Asset Management first reported a position in Stemline Therapeutics, Inc. in Q3 2018 and held it in 6 quarters.
Sectoral Asset Management's Stemline Therapeutics, Inc. position peaked at $10.9M in Q4 2019.
94 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q1 2020.

Based on Sectoral Asset Management's 13F filing for Q1 2020, filed 13 May 2020.